Byrne Asset Management LLC Amgen Inc Transaction History

Byrne Asset Management LLC

$116 Million
Q2 2024

A detailed history of Byrne Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Byrne Asset Management LLC holds 1,292 shares of AMGN stock, worth $361,772. This represents 0.35% of its overall portfolio holdings.

Number of Shares

1,292

Previous 1,467 11.93%

Holding current value

$361,772

Previous $417,000 3.36%

% of portfolio

0.35%

Previous 0.35%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$262.75 - $319.31 $45,981 - $55,879	-175 Reduced 11.93%	1,292 $403,000
Q1 2024 Apr 22, 2024	SELL	$268.87 - $324.56 $13,712 - $16,552	-51 Reduced 3.36%	1,467 $417,000
Q4 2023 Jan 29, 2024	SELL	$255.7 - $288.46 $1,789 - $2,019	-7 Reduced 0.46%	1,518 $437,000
Q3 2023 Oct 31, 2023	BUY	$218.65 - $271.46 $1,967 - $2,443	9 Added 0.59%	1,525 $409,000
Q2 2023 Jul 21, 2023	BUY	$214.27 - $253.37 $74,994 - $88,679	350 Added 30.02%	1,516 $336,000
Q1 2023 Apr 17, 2023	BUY	$225.79 - $275.2 $48,544 - $59,168	215 Added 22.61%	1,166 $281,000
Q4 2022 Jan 30, 2023	SELL	$229.03 - $291.01 $26,109 - $33,175	-114 Reduced 10.7%	951 $249,000
Q3 2022 Oct 19, 2022	BUY	$224.46 - $253.15 $4,264 - $4,809	19 Added 1.82%	1,065 $240,000
Q2 2022 Jul 20, 2022	BUY	$230.71 - $256.74 $58,600 - $65,211	254 Added 32.07%	1,046 $254,000
Q1 2022 Apr 05, 2022	BUY	$219.27 - $242.57 $4,385 - $4,851	20 Added 2.59%	792 $192,000
Q4 2021 Feb 22, 2022	BUY	$198.88 - $227.6 $153,535 - $175,707	772 New	772 $174,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Byrne Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Byrne Asset Management LLC with notifications on news.

Account

Byrne Asset Management LLC Amgen Inc Transaction History